Drug tracked in tissue

October 17, 2011
Drug tracked in tissue

When a new drug is developed, the manufacturer must be able to show that it reaches its intended goal in the body's tissue, and only that goal. Such studies could be made easier with a new method now established at Lund University in Sweden.

The method is a special type of which can be used on drugs 'off the shelf', i.e. without any radioactive labelling which may change the behaviour of the . With this method, researchers György Marko-Varga and Thomas Fehniger have managed to create a molecular image of the drug in the tissue.

The tissue examined comes from biopsies from the lungs of patients with lung cancer and chronic obstructive lung disease (COPD), who have inhaled a drug to dilate the airways. The examination showed the precise spatial distribution of the drug within the tissue. The results are based on an analysis of 3 000 measurement points of 0.01 mm2 in each biopsy sample.

"When you want to register a new drug, you must be able to both explain its exact mechanisms of action and show that it is effective and safe. In order to avoid side-effects, the drug should reach only the cells for which it is intended. Our new technical platform makes it easier to show this", says György Marko-Varga.

He believes it will be possible to use the new technology to develop safer and more effective drug candidates. In the future it could also be used in clinical treatment, to help doctors select the right drug for a specific patient.

The researchers first conducted animal experiments, using drug doses 100 times higher than those now measured in patients. The group then optimised and refined the technology to achieve the sensitivity needed for measuring doses of drugs normally administered to patients.

Professors György Marko-Varga and Thomas Fehniger are both members of the Department of Measurement Technology and Industrial Electrical Engineering in Lund. Thomas Fehniger (who is the principal author of the article) is currently working at The Tallinn University of Technology, sponsored by the Estonian Science Foundation under the European Social Fund, while György Marko-Varga works part time for the University of Tokyo.

The two researchers have previously worked at the pharmaceuticals company AstraZeneca, which has also contributed to the study. The study was recently published in the journal Analytical Chemistry.

Explore further: New cancer drug test promises safer and more effective clinical trials

More information: A text about the research findings is available at pubs.acs.org/cen/news/89/i41/8941scene.html and the research article is available at pubs.acs.org/doi/abs/10.1021/ac2014349

Related Stories

A new method for developing safer drugs

May 10, 2010

Amodiaquine was introduced as an antimalarial drug, but was withdrawn when serious adverse effects were observed. Scientists at the University of Gothenburg, Sweden, have now developed a method that can be used to develop ...

Electronic nose detects cancer

December 20, 2010

Gyorgy Horvath from the University of Gothenburg, Sweden, and researchers from the University of Gavle and KTH Royal Institute of Technology have been able to confirm in tests that ovarian cancer tissue and healthy tissue ...

Lund adopts chromosome 19

February 3, 2011

The genes that make up the human genome were mapped by HUGO, the Human Genome Organisation, and published in 2001. Now the project is expanding into the HUPO, the Human Proteome Organisation. Within the framework of this ...

Recommended for you

Room-temperature lithium metal battery closer to reality

February 4, 2016

Rechargeable lithium metal batteries have been known for four decades to offer energy storage capabilities far superior to today's workhorse lithium-ion technology that powers our smartphones and laptops. But these batteries ...

Uncovering secrets of elastin's flexibility during assembly

February 5, 2016

Elastin is a crucial building block in our bodies - its flexibility allows skin to stretch and twist, blood vessels to expand and relax with every heartbeat, and lungs to swell and contract with each breath. But exactly how ...

Researchers seek efficient means of splitting water

February 5, 2016

Photovoltaics promise to help meet our energy needs by turning sunlight into electricity. We can't run everything that way, but with a little tweaking, photovoltaic materials can use solar energy to split water into hydrogen ...

Antibiotic's killer strategy revealed

February 4, 2016

Using a special profiling technique, scientists at Princeton have determined the mechanism of action of a potent antibiotic, known as tropodithietic acid (TDA), leading them to uncover its hidden ability as a potential anticancer ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.